| Product ID |
CAS Number |
Product Name |
Quantity |
| AS-0700 |
5779-95-3 |
3,5-Dimethylbenzaldehyde |
|
| AS-0704 |
500-66-3 |
Olivetol |
|
| AS-1140 |
13400-13-0 |
Caesium fluoride |
|
| AS-1405 |
1188-21-2 |
N-Acetyl-L-leucine |
|
| AS-1832 |
1123-56-4 |
2,6-Dimethylbenzaldehyde |
|
| AS-2087 |
52200-48-3 |
3-Bromo-2-chloropyridine |
|
| AS-2615 |
59907-12-9 |
3-Bromo-2-fluorotoluene |
|
| AS-2805 |
313545-41-4 |
2-Chloro-4-(trifluoromethyl)phenylboronic acid |
|
| AS-3007 |
146328-85-0 |
5-Bromo-2-fluorobenzoic acid |
|
| AS-3554 |
83846-83-7 |
KETANSERIN TARTRATE |
|
| AS-4673 |
174565-65-2 |
5-nitroquinazoline-2,4(1H,3H)-dione |
|
| AS-4767 |
26050-64-4 |
4-BROMO-3,5-DIMETHOXYBENZOIC ACID METHYL ESTER |
|
| AS-4819 |
17282-00-7 |
2-Amino-3-bromo-5-methylpyridine |
|
| AS-4919 |
5367-32-8 |
3-Methyl-4-nitroanisole |
|
| AS-4936 |
586-30-1 |
3-Hydroxy-4-methylbenzoic acid |
|
| AS-5040 |
177721-53-8 |
N-CYCLOBUTYL-4-AMINOCYCLOHEXANONE ETHYLENE KETAL |
|
| AS-5652 |
189028-93-1 |
(4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone |
|
| AS-6013 |
68832-13-3 |
D(-)Prolinol |
|
| AS-6329 |
32443-99-5 |
D-Cysteine hydrochloride |
|
| AS-6372 |
3392-05-0 |
Succinimido (S)-2-[(tert-butoxycarbonyl)amino]propionate |
|
| AS-7193 |
5192-23-4 |
4-Aminoindole |
|
| AS-7256 |
67579-81-1 |
TRANS-1,2-BIS(METHYLAMINO)CYCLOHEXANE |
|
| AS-7519 |
19621-92-2 |
6-Hydroxypicolinic acid |
|
| AS-7525 |
66-84-2 |
D-Glucosamine hydrochloride |
|
| AS-8319 |
6199-67-3 |
CUCURBITACIN B |
|
| AS-8598 |
39207-65-3 |
2-Isobutyrylcyclohexanone |
|
| AS-8879 |
389621-78-7 |
4-Aminomethyltetrahydropyran hydrochloride |
|
| AS-8933 |
165454-06-8 |
CBZ-8-AMINO-3,6-DIOXAOCTANOIC ACID DCHA |
|
| JR6-L3815 |
1414976-28-5 |
Benzenemethanamine, N-[[(1R,2R)-2-(1,3-dioxolan-2-yl)cyclopentyl]methyl]- |
|
| JR6-L4876 |
749929-04-2 |
Cyclobutanecarbonitrile, 1-(4-bromo-2-fluorophenyl)- |
|
| JR6-L7461 |
1335785-65-3 |
3-Pyridineethanamine, 5-amino-a-methyl-, (aR)- |
|
| JR8-N0041 |
501-36-0 |
Resveratrol |
|
| JR8-N0484 |
|
Praeruptorin D |
|
|
|
|
|
|
|
|
|
|
|
|
|